share_log

关于河南羚锐制药股份有限公司2021年限制性股票激励计划第三期解锁条件成就及回购注销部分限制性股票之专项法律意见书

Special Legal Opinion on the Achievement of Unlocking Conditions and Repurchase and Cancellation of Restricted Stocks of the Third Restricted Stock Incentive Plan of Henan Lingrui Pharmaceutical Co., Ltd. in 2021

Sensex a share ·  Jun 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more